Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

U S Physical Therapy (USPH) Shares Issued (2023)

U S Physical Therapy (USPH) has disclosed Shares Issued for 2 consecutive years, with -$9000.0 as the latest value for Q3 2023.

Quarterly Shares Issued changed N/A to -$9000.0 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was -$9000.0 through Dec 2024, changed 0.0% year-over-year, with the annual reading at $163.6 million for FY2023, N/A changed from the prior year.
Shares Issued hit -$9000.0 in Q3 2023 for U S Physical Therapy, down from $16000.0 in the prior quarter.
In the past five years, Shares Issued ranged from a high of -$9000.0 in Q3 2023 to a low of -$9000.0 in Q3 2023.